Certara, Inc. - SaaS Valuation Profile CERT

Certara, Inc. is a leading provider of biosimulation and regulatory science technology for the pharmaceutical, biotechnology, and academic research industries. Founded in 2008 (incorporating capabilities developed over 20+ years by predecessor entities) and headquartered in Princeton, New Jersey, Certara provides software and scientific consulting services that use mathematical modeling and simulation to predict drug behavior, optimize clinical trial design, and support regulatory submissions to agencies like the FDA and EMA.

The company's flagship software platform, Simcyp, is a population-based pharmacokinetic/pharmacodynamic (PBPK) modeling and simulation tool used to predict how drugs will behave in diverse patient populations before clinical trials begin. Phoenix WinNonlin is the industry standard for noncompartmental and compartmental pharmacokinetic analysis. D360 is a cloud-based data analytics platform for drug discovery and development decision-making. Together, these tools help pharmaceutical companies reduce the time, cost, and failure rate of drug development by replacing or supplementing physical experiments with virtual simulations.

Certara's regulatory science and consulting division provides model-informed drug development (MIDD) services, including submission-ready pharmacometric analyses, clinical pharmacology strategies, market access analytics, and real-world evidence studies. The company's technology and expertise are increasingly recognized by regulatory agencies — the FDA has used Certara's Simcyp simulator internally, and model-informed approaches are now encouraged in regulatory guidance.

Certara serves approximately 2,100 customers globally, including all of the top 35 pharmaceutical companies by R&D spending, along with hundreds of biotech firms, CROs, and academic institutions. The company generates approximately $400 million in annual revenue, with a mix of software subscriptions and technology-driven consulting services. Software revenue carries gross margins above 80%. Certara employs approximately 1,600 people across offices in the U.S., Europe, and Asia.